Clinical Trial Update: Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating SHR-1501 in combination with Adbelizumab for patients with advanced or metastatic cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Adbelizumab
• SHR-1501

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Patients With Advanced or Metastatic Malignant Tumors | Phase 1, Phase 2 | Status: RECRUITING